MIT Technology Review
PRECISION ONCOLOGY
July 2025
The oncology of the future has genomics as one of its main pillars. With predictive tests that analyze the expression of multiple genes, it is possible to personalize cancer treatment and optimize both the patient journey and healthcare system resources.
In breast cancer, the most commonly diagnosed cancer in women in Brazil, tests can determine whether chemotherapy will bring more benefits than harm.
This helps avoid unnecessary treatments and their adverse effects, contributing to a more precise and individualized approach.